Guest guest Posted July 4, 2006 Report Share Posted July 4, 2006 After a frustrating time to get the full text of the pomegranate article, which was promised for publication July 1 but never made it online. I was able to purchase it y/day and have expanded my report: http://psa-rising.com/eatingwell/pomegranate-juice06.htm Ill talk to the researcher to see he can let me post the entire article on psa-rising.com. For now I've extracted more than the gist. Couple of issues brought up by members of PCa lists are clearer now. Firstly, the researchers deny any estrogneic effect of pomegranate is involved in the lowering of PSA. They say testosterone did not not fall in the patients. " Patients were followed in 3-month intervals for serum PSA, and blood and urine were collected for laboratory studies. In addition measurements were made of the effect of pomegranate on the patients' hormone levels (testosterone, estradiol, sex hormone-binding globulin, dehydroepiandrosterone, insulin-like growth factor, and androstenedione). " They found no effect on testosterone levels. An earlier study (PNAS, 2005), which Dr. Ignarro edited on behalf of a group in Wisconsin, found that pomegranate downregulates the androgen receptor on prostate cancer cells. Pantuck makes no reference to this but states: " The lack of any observed effect on serum androgen levels suggests that the effect is not primarily hormonal in nature. " Secondly they state that they don't believe PSA was lowered only " artifactually, " i.e. lowered by some fluke effect of polyphenol content of the juice without any change in the cancer. They say their view is: " is supported by a separate pharmacokinetic study (data not shown), in which there was no relationship between circulating ellagic acid and PSA when both were serially and simultaneously measured after pomegranate juice consumption. " Patients: Of the patients enrolled, 68% were originally treated by radical prostatectomy, 10% by external beam radiotherapy, 10% by brachytherapy, 7% by surgery and radiation, and 5% by cryotherapy. The original Gleason scores were read as intermediate (5-7} in 94% of patients, whereas 6% had Gleason 4 cancers. All patients were clinical or pathologic N 0 and M 0, and 63% were clinically or pathologically staged with organ- confined disease, whereas 37% had locally advanced cancers extending into the periprostatic or seminal vesicle tissues. At study entry, median PSA for the cohort was 1.05 ng/mL (average, 2.23 ± 2.58 ng/mL). A series of PSA measurements before study entry determined each patient's baseline PSA doubling time (PSADT). Each patient had a minimum of three pretreatment PSA values measured over a minimum of 6 months before study entry. Juice dose: " Patients were treated with 8 ounces of pomegranate juice by mouth daily (Wonderful variety, equivalent to 570 mg total polyphenol gallic acid equivalents daily) until meeting disease progression end points. " Method of producing the juice is descrbed (on my psa-r page, near the bottom). Results: Essentially what was previously reported,in more detail. I have posted a chart of the log PSA slopes of the patients, its quite scrambled, but take a look. Click on it and it will enlarge. I expect to continue editing this page and might turn their patient results into a table if that helps. For now Jacquie Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 4, 2006 Report Share Posted July 4, 2006 After reading this information, I went to the local grocery and bought some pomegranate juice, and ya know what? This was the first time I had ever tasted it, and it's delicious!!! Actually, it is a combination of blueberry and pomegranate, but if 8 ounces of this stuff a day will help, then why not? Thanks for the information. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.